Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease

NCT02121054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1527

Last updated 2023-03-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.

Conditions

Sponsors & Collaborators

  • Young-Hak Kim, MD, PhD

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-19
Primary Completion
2020-10-29
Completion
2020-10-29

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02121054 on ClinicalTrials.gov